CCM
IMMX icon

Corsair Capital Management’s Immix Biopharma IMMX Stock Holding History

Corsair Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,217
Closed -$28.1K – 126
2024
Q2 		$28.1K Sell
14,217
-55,168
-80% -$127K ﹤0.01% 101
2024
Q1 		$213K Buy
+69,385
New +$269K 0.06% 87

Other funds holding IMMX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corsair Capital Management's IMMX Position: Q3 2024 in Review

Corsair Capital Management sold out of Immix Biopharma (IMMX) in Q3 2024, closing a stake of 14,217 shares — an estimated $28.1K sold.

Corsair Capital Management first reported a position in IMMX in Q1 2024 and held it in 2 quarters. The position peaked at $213K in Q1 2024. 25 funds tracked by Wall St. Rank hold IMMX as of Q3 2024.

  • Corsair Capital Management reported no remaining Immix Biopharma position as of Q3 2024 after selling out during the quarter.
  • Corsair Capital Management sold 14,217 Immix Biopharma shares in Q3 2024, an estimated $28.1K.
  • Corsair Capital Management first reported a position in Immix Biopharma in Q1 2024 and held it in 2 quarters.
  • Corsair Capital Management's Immix Biopharma position peaked at $213K in Q1 2024.
  • 25 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2024.

Based on Corsair Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.